DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Wallentin L, Hijazi Z, Andersson U. et al.
Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Circulation 2014;
130: 1847-1858.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.